Clinical decision diagram comparing PDRN polynucleotide treatment pathway with HA skin booster pathway for aesthetic patient selection

PDRN vs HA Skin Boosters: Which Is Right for Your Patient?

As PDRN (polydeoxyribonucleotide) products enter mainstream aesthetic practice, one of the most common questions practitioners ask is deceptively simple: for a given patient, should I use PDRN or a HA skin booster? The question is deceptive because it implies a binary choice where the more useful clinical framing is a spectrum — with most patients sitting somewhere in the middle where both could offer benefit, and the skill lying in knowing which mechanism addresses their dominant concern more directly.